No. OncoK9 is indicated for use in domestic canids only (pet dogs). Dogs and cats have unique genomes. OncoK9 has been uniquely designed to only work in dogs. In the future, we hope to be able to extend this technology to cats.
The OncoK9 test does not provide a diagnosis of cancer and is meant to be used alongside existing clinical evaluation. The test’s results must be confirmed by established methods (such as tissue analysis) in order to arrive at a definitive ...
OncoK9 is designed to fit in easily with the current paradigm of care, where most dogs are seeing their veterinarian on an annual basis. Screening using OncoK9 should be performed at regular intervals over time, with the goal of identifying cancer ...
OncoK9 is a multi-cancer early detection (MCED) test for the detection and characterization of cancer-associated genomic alterations in DNA isolated from canine whole blood samples, using next-generation sequencing technology. OncoK9 is intended for ...
Whole blood transfusions that contain white blood cells may interfere with the OncoK9 test. Patients that have received a whole blood transfusion need to wait 3 months before having an OncoK9 test performed. Patients who have been transfused only ...
The clinical performance characteristics of the OncoK9 were determined in training and validation cohorts comprising over 1000 dogs, with and without a diagnosis of cancer, as part of the CANDiD (CANcer Detection in Dogs) Study. The study ...